Here are some of the latest health and medical news
developments, compiled by the editors of HealthDay:
Sugar Trumps Fat in Driving Unhealthy Eating: Study
Sugar, not fat, is the major reason why people are drawn to
unhealthy treats, a new study says.
Researchers monitored the brain activity of more than 100 teens
as they drank chocolate-flavored milkshakes that had the same
number of calories but were either high in sugar and low in fat, or
the other way around,
The New York Timesreported.
Both types of shakes activated pleasure centers in the brain,
but those that were high in sugar did so far more effectively and
triggered a food reward network involved in compulsive eating,
according to the study in
The American Journal of Clinical Nutrition.
The findings add to a growing body of research that's improving
understanding of what causes overeating.
"We do a lot of work on the prevention of obesity, and what is really clear not only from this study but from the broader literature over all is that the more sugar you eat, the more you want to consume it," study lead author Eric Stice, a senior research scientist at the Oregon Research Institute, told The Times.
"As far as the ability to engage brain reward regions and drive compulsive intake, sugar seems to be doing a much better job than fat," he said.
14 Million Cancer Diagnoses Worldwide in 2012: Report
The number of people worldwide diagnosed with cancer climbed
from 12.7 million in 2008 to 14 million in 2012, and the number of
cancer deaths increased from 7.6 million to 8.2 million, a new
The rising rates of cancer cases and deaths are due higher rates
of smoking and obesity, as well as the fact that people are living
longer, according to the World Health Organization study,
The 1.8 million cases of lung cancer made it the most common
type of cancer in 2012, accounting for about 13 percent of all
cancers. There was also a sharp rise in breast cancer cases and
deaths since 2008, and it is now the most common cancer in women in
The WHO predicted that the number of cancer cases worldwide will
rise to more than 19 million a year by 2025,
FDA Approves Generic Versions of Antidepressant Cymbalta
The first generic versions of the antidepressant Cymbalta have
been approved by the U.S. Food and Drug Administration.
The agency okayed six generic versions of the drug from a number
of companies, including Teva Pharmaceuticals, Sun Pharma Global and
Dr. Reddy's Laboratories Ltd., the
Cymbalta, the fifth best selling medication in the world in
2012, is marketed by Eli Lilly & Co. Inc. The company's patent
on Cymbalta expired Wednesday. Generic drugs typically sell for
much less than the original branded product.
Along with depression, Cymbalta is also used to treat
generalized anxiety disorder, fibromyalgia, diabetic nerve pain,
and some types of chronic pain, the
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Information Services. All rights reserved.